J Physiol (London) 428:155-172
As researchers delve deeper into mitochondrial health and multi-agonist peptide therapies, the potential synergy between MOTS-c, a mitochondrial-derived peptide, and Retatrutide, a triple-agonist, sparks significant interest
Last updated February 29, 2024
Before making any investment decision, an investor should refer to a structured notes offering documents for additional information and obtain advice from their financial, legal and tax professionals for information about and analysis of the investment, its risks and its appropriateness in their particular circumstances
Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro
Available on the World Wide Web Ohman I, Vitols S, Luef G, et al